Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Caddick

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Nature Chemical Biology|September 19, 2018
Post-translational site-selective protein backbone α-deuterationSébastien R G Galan, James R Wickens, Jitka Dadova, et al.
Scientific Reports|March 23, 2013
Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'Felix F Schumacher, Vishal A Sanchania, Berend Tolner, et al.
Tetrahedron Letters|September 24, 2013
A mild synthesis of N-functionalised bromomaleimides, thiomaleimides and bromopyridazinedionesLourdes Castañeda, Zoë V F Wright, Cristina Marculescu, et al.
British Journal of Cancer|September 11, 2020
Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancerMichelle K Greene, Ting Chen, Eifion Robinson, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Nature Chemical Biology|September 19, 2018
Post-translational site-selective protein backbone α-deuterationSébastien R G Galan, James R Wickens, Jitka Dadova, et al.
Scientific Reports|March 23, 2013
Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'Felix F Schumacher, Vishal A Sanchania, Berend Tolner, et al.
Tetrahedron Letters|September 24, 2013
A mild synthesis of N-functionalised bromomaleimides, thiomaleimides and bromopyridazinedionesLourdes Castañeda, Zoë V F Wright, Cristina Marculescu, et al.
British Journal of Cancer|September 11, 2020
Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancerMichelle K Greene, Ting Chen, Eifion Robinson, et al.
Pageof 9